MET and neoplasm: Other tumor biomarkers have been proposed such as osteopontin (OPN), vascular endothelial growth factor (VEGF), angiopoietin 2 (ANG-2), Golgi protein 73 (Gp-73), insulin growth factor-1 (IGF-1), hepatic growth factor (HGF), Glypican-3 and c-MET among others.